Syneos Health Reports Second Quarter 2022 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/30/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- BioNTech ends colorectal cancer mRNA therapy trial early
- Needham sees mature node semiconductor strength in latest tracker
Syneos (SYNH) PT Lowered to $70 at Jefferies
August 3, 2022 8:11 AM EDTJefferies analyst David Windley lowered the price target on Syneos (NASDAQ: SYNH) to $70.00 (from $75.00) while maintaining a Hold rating.
The analyst commented, "Investors should suppress their inclination to view this as: 1) company-specific to SYNH, and 2) a near-term buying opportunity in SYNH. We... More
ObsEva SA (SYNH) Tops Q2 EPS by 5c
August 2, 2022 6:15 AM EDTObsEva SA (NASDAQ: SYNH) reported Q2 EPS of $1.25, $0.05 better than the analyst estimate of $1.20. Revenue for the quarter came in at $1.36 billion versus the consensus estimate of $1.39 billion.
GUIDANCE:
ObsEva SA sees FY2022 EPS of $4.97-$5.11, versus the consensus... More
